Anna Elinder Camburn
0000-0002-6097-7839
1 paper found
Refreshing results…
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia
Missing publications? Search for publications with a matching author name.